Topical photodynamic therapy in dermatology.

Although photodynamic therapy (PDT) was first used in the treatment of skin diseases, phase-III-clinical trials were primarily conducted for the treatment of bladder cancer, endobronchial and oesophageal carcinoma. In dermatology PDT has most extensively been used for the treatment of malignant cutaneous lesions. Up to now those patients have been treated systemically with first-generation photosensitizers. However, prolonged skin photosensitivity is a major disadvantage of this form of therapy. Topical PDT utilizing a variety of sensitizers bypass this unwanted effect. Of strong interest is 5-aminolevulinic acid (ALA), first introduced in the topical PDT of skin disorders in 1990 by Kennedy and co-workers. ALA serves as a pro-drug, i.e. the active photosensitizing compound is protoporphyrin IX which is synthesized in vivo after exogenous application of ALA. In several oncologic and non-oncologic skin conditions including non-melanoma skin cancer, premalignant conditions like actinic keratoses and in psoriasis, topical ALA-PDT showed it's effectiveness. Besides ALA, new sensitizers like benzoporphyrines and porphycenes may play a role in topical PDT. However, at the moment, there is still a need for comparative studies and standardized therapeutic protocols to define the place of topical PDT in Dermatology.

[1]  S. Arkins,et al.  PHOTODESTRUCTION OF TUMOR CELLS BY INDUCTION OF ENDOGENOUS ACCUMULATION OF PROTOPORPHYRIN IX: ENHANCEMENT BY 1, 10‐PHENANTHROLINE , 1992, Photochemistry and photobiology.

[2]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[3]  N. Cascinelli,et al.  Topical Administration of Tetrasodium-Mesotetraphenyl-Porphinesulfonate (TPPS) and Red Light Irradiation for the Treatment of Superficial Neoplastic Lesions , 1987, Tumori.

[4]  G. Hüttmann,et al.  [Photodynamic therapy of eyelid basalioma after topical administration of delta-aminolevulinic acid]. , 1994, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[5]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[6]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[7]  M W Berns,et al.  Benzoporphyrin Derivative: A Potent Photosensitizer for Photodynamic Destruction of Rabbit Endometrium , 1994, Obstetrics and gynecology.

[8]  Kevin C. Smith,et al.  Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative , 1988, Lasers in surgery and medicine.

[9]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[10]  A. Abramson,et al.  Clinical exacerbation of systemic lupus erythematosus after photodynamic therapy of laryngotracheal papillomatosis , 1993, Lasers in surgery and medicine.

[11]  M Landthaler,et al.  PENETRATION POTENCY OF TOPICAL APPLIED δ‐AMINOLEVULINIC ACID FOR PHOTODYNAMIC THERAPY OF BASAL CELL CARCINOMA * , 1994, Photochemistry and photobiology.

[12]  G. Weinstein,et al.  Development of a topical hematoporphyrin derivative formulation: characterization of photosensitizing effects in vivo. , 1983, The Journal of investigative dermatology.

[13]  M. Landthaler,et al.  Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. , 1996, Dermatology.

[14]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[15]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[16]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[17]  H Kerl,et al.  Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.

[18]  P. Charlesworth,et al.  The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). , 1993, Journal of photochemistry and photobiology. B, Biology.

[19]  A Tanew,et al.  Lethal photosensitization by endogenous porphyrins of PAM cells--modification by desferrioxamine. , 1993, Journal of photochemistry and photobiology. B, Biology.

[20]  G. Kuhnle,et al.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. , 1994, British Journal of Cancer.

[21]  J C Kennedy,et al.  Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.

[22]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[23]  J Hanania,et al.  The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. , 1992, Cancer letters.

[24]  M Landthaler,et al.  A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. , 1994, Acta dermato-venereologica.

[25]  H. Kerl,et al.  Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.

[26]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[27]  K König,et al.  In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.

[28]  J. Wessels,et al.  Photodynamic antitumor agents: beta-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity. , 1994, Journal of medicinal chemistry.